nodes	percent_of_prediction	percent_of_DWPC	metapath
Desonide—NR3C1—Fluoxymesterone—breast cancer	0.284	1	CbGbCtD
Desonide—Testolactone—Exemestane—breast cancer	0.0394	0.0712	CrCrCtD
Desonide—Prednisone—Exemestane—breast cancer	0.0353	0.0638	CrCrCtD
Desonide—Fluprednidene Acetate—Exemestane—breast cancer	0.0328	0.0592	CrCrCtD
Desonide—Loteprednol—Exemestane—breast cancer	0.0328	0.0592	CrCrCtD
Desonide—Methylprednisolone—Exemestane—breast cancer	0.0306	0.0554	CrCrCtD
Desonide—Prednisolone—Exemestane—breast cancer	0.03	0.0542	CrCrCtD
Desonide—Hydrocortamate—Fluoxymesterone—breast cancer	0.029	0.0525	CrCrCtD
Desonide—Testolactone—Fluoxymesterone—breast cancer	0.0273	0.0494	CrCrCtD
Desonide—Amcinonide—Fluoxymesterone—breast cancer	0.0251	0.0454	CrCrCtD
Desonide—Fludrocortisone—Fluoxymesterone—breast cancer	0.0244	0.0442	CrCrCtD
Desonide—Clobetasol propionate—Fluoxymesterone—breast cancer	0.0244	0.0442	CrCrCtD
Desonide—Desoximetasone—Fluoxymesterone—breast cancer	0.0233	0.0421	CrCrCtD
Desonide—Fluprednidene Acetate—Fluoxymesterone—breast cancer	0.0227	0.0411	CrCrCtD
Desonide—Fluorometholone—Fluoxymesterone—breast cancer	0.0227	0.0411	CrCrCtD
Desonide—Loteprednol—Fluoxymesterone—breast cancer	0.0227	0.0411	CrCrCtD
Desonide—Mometasone—Fluoxymesterone—breast cancer	0.0227	0.0411	CrCrCtD
Desonide—Triamcinolone—Fluoxymesterone—breast cancer	0.0227	0.0411	CrCrCtD
Desonide—Dexamethasone—Fluoxymesterone—breast cancer	0.0222	0.0401	CrCrCtD
Desonide—Betamethasone—Fluoxymesterone—breast cancer	0.0222	0.0401	CrCrCtD
Desonide—Prednisolone—Fluoxymesterone—breast cancer	0.0208	0.0376	CrCrCtD
Desonide—Hydrocortisone—Fluoxymesterone—breast cancer	0.0199	0.0361	CrCrCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—AFP—breast cancer	0.000564	0.0101	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—RXRB—breast cancer	0.000555	0.00993	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—RARB—breast cancer	0.000523	0.00937	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—KRT5—breast cancer	0.000516	0.00924	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—KRT14—breast cancer	0.00048	0.00859	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—NR2F1—breast cancer	0.000471	0.00843	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—EBF1—breast cancer	0.000438	0.00784	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—SLC2A2—breast cancer	0.000423	0.00758	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—PGR—breast cancer	0.000416	0.00744	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1A—breast cancer	0.000415	0.00743	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—RARB—breast cancer	0.000413	0.0074	CbGpPWpGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA2—breast cancer	0.000409	0.00732	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—DLX2—breast cancer	0.000378	0.00678	CbGpPWpGaD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—breast cancer	0.00037	0.00662	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—PABPC1—breast cancer	0.000367	0.00658	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—ESR2—breast cancer	0.000366	0.00655	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—LEP—breast cancer	0.00036	0.00645	CbGpPWpGaD
Desonide—Fluocinolone Acetonide—PLA2G4A—breast cancer	0.000347	0.104	CrCbGaD
Desonide—NR3C1—Circadian Clock—CPT1A—breast cancer	0.000347	0.00621	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—HSP90AA1—breast cancer	0.000347	0.00621	CbGpPWpGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA1—breast cancer	0.000344	0.00617	CbGpPWpGaD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—breast cancer	0.000343	0.00615	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—TWIST1—breast cancer	0.000332	0.00594	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—PGR—breast cancer	0.000328	0.00588	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—AR—breast cancer	0.000323	0.00579	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—DKK1—breast cancer	0.000312	0.00559	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—NCOA2—breast cancer	0.000307	0.00549	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—WNT10B—breast cancer	0.000304	0.00543	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—NCOA2—breast cancer	0.000298	0.00533	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—VDR—breast cancer	0.00029	0.0052	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—ESR2—breast cancer	0.000289	0.00518	CbGpPWpGaD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—breast cancer	0.000289	0.00517	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—NRIP1—breast cancer	0.000282	0.00505	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—PTHLH—breast cancer	0.000272	0.00487	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—HSP90AA1—breast cancer	0.000266	0.00476	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—EGR1—breast cancer	0.000262	0.0047	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—PRLR—breast cancer	0.00026	0.00466	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—MIF—breast cancer	0.00026	0.00466	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—NCOA1—breast cancer	0.000258	0.00463	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—HADHB—breast cancer	0.000256	0.00458	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—YBX1—breast cancer	0.000256	0.00458	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—AR—breast cancer	0.000255	0.00457	CbGpPWpGaD
Desonide—Testolactone—CYP19A1—breast cancer	0.000251	0.0754	CrCbGaD
Desonide—NR3C1—Circadian Clock—NCOA1—breast cancer	0.000251	0.00449	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—ZNF432—breast cancer	0.000248	0.00444	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—EZH2—breast cancer	0.000248	0.00444	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—AR—breast cancer	0.000248	0.00444	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—breast cancer	0.000247	0.00443	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—THRB—breast cancer	0.000244	0.00437	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—DDIT3—breast cancer	0.000244	0.00436	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—VDR—breast cancer	0.00023	0.00411	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—SIRT1—breast cancer	0.000226	0.00404	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—breast cancer	0.000222	0.00398	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptors—ESR1—breast cancer	0.000222	0.00397	CbGpPWpGaD
Desonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—breast cancer	0.000222	0.00397	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—TCF7L2—breast cancer	0.000221	0.00395	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—GATA3—breast cancer	0.00022	0.00394	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA2—breast cancer	0.000218	0.00391	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—NCOA2—breast cancer	0.000216	0.00387	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—PPARGC1B—breast cancer	0.000211	0.00377	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—breast cancer	0.00021	0.00377	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—NCOR1—breast cancer	0.00021	0.00376	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—EGR1—breast cancer	0.00021	0.00376	CbGpPWpGaD
Desonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—breast cancer	0.000207	0.0037	CbGpPWpGaD
Desonide—Stinging—Doxorubicin—breast cancer	0.000206	0.00199	CcSEcCtD
Desonide—Erythema—Vinorelbine—breast cancer	0.000205	0.00198	CcSEcCtD
Desonide—Cough—Melphalan—breast cancer	0.000205	0.00197	CcSEcCtD
Desonide—Rash—Exemestane—breast cancer	0.000203	0.00196	CcSEcCtD
Desonide—Mediastinal disorder—Thiotepa—breast cancer	0.000203	0.00195	CcSEcCtD
Desonide—Dermatitis—Exemestane—breast cancer	0.000203	0.00195	CcSEcCtD
Desonide—Pruritus—Letrozole—breast cancer	0.000202	0.00195	CcSEcCtD
Desonide—Pruritus—Anastrozole—breast cancer	0.000202	0.00195	CcSEcCtD
Desonide—Sweating—Gemcitabine—breast cancer	0.000202	0.00195	CcSEcCtD
Desonide—Headache—Exemestane—breast cancer	0.000202	0.00194	CcSEcCtD
Desonide—Cough—Goserelin—breast cancer	0.0002	0.00193	CcSEcCtD
Desonide—Viral infection—Epirubicin—breast cancer	0.0002	0.00193	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—breast cancer	0.0002	0.00358	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Melphalan—breast cancer	0.000199	0.00191	CcSEcCtD
Desonide—Mental disorder—Thiotepa—breast cancer	0.000197	0.0019	CcSEcCtD
Desonide—Erythema—Thiotepa—breast cancer	0.000196	0.00189	CcSEcCtD
Desonide—NR3C1—Adipogenesis—AHR—breast cancer	0.000196	0.0035	CbGpPWpGaD
Desonide—Infection—Tamoxifen—breast cancer	0.000194	0.00187	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Goserelin—breast cancer	0.000194	0.00187	CcSEcCtD
Desonide—Pharyngitis—Mitoxantrone—breast cancer	0.000193	0.00186	CcSEcCtD
Desonide—Rash—Ixabepilone—breast cancer	0.000191	0.00185	CcSEcCtD
Desonide—Dermatitis—Ixabepilone—breast cancer	0.000191	0.00184	CcSEcCtD
Desonide—Infection—Melphalan—breast cancer	0.00019	0.00183	CcSEcCtD
Desonide—Headache—Ixabepilone—breast cancer	0.00019	0.00183	CcSEcCtD
Desonide—Hyperhidrosis—Tamoxifen—breast cancer	0.000189	0.00182	CcSEcCtD
Desonide—Pain—Chlorambucil—breast cancer	0.000188	0.00181	CcSEcCtD
Desonide—Pharyngitis—Gemcitabine—breast cancer	0.000188	0.00181	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—HSP90AA1—breast cancer	0.000187	0.00335	CbGpPWpGaD
Desonide—Oedema peripheral—Gemcitabine—breast cancer	0.000186	0.0018	CcSEcCtD
Desonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—breast cancer	0.000186	0.00334	CbGpPWpGaD
Desonide—Skin disorder—Melphalan—breast cancer	0.000186	0.00179	CcSEcCtD
Desonide—Infection—Goserelin—breast cancer	0.000186	0.00179	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—EGR1—breast cancer	0.000185	0.00331	CbGpPWpGaD
Desonide—Viral infection—Doxorubicin—breast cancer	0.000185	0.00178	CcSEcCtD
Desonide—Pharyngitis—Fluorouracil—breast cancer	0.000185	0.00178	CcSEcCtD
Desonide—Skin exfoliation—Methotrexate—breast cancer	0.000184	0.00177	CcSEcCtD
Desonide—Upper respiratory tract infection—Paclitaxel—breast cancer	0.000184	0.00177	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA1—breast cancer	0.000184	0.0033	CbGpPWpGaD
Desonide—Nervous system disorder—Goserelin—breast cancer	0.000183	0.00177	CcSEcCtD
Desonide—Fludrocortisone—AR—breast cancer	0.000183	0.0549	CrCbGaD
Desonide—NR3C1—Endoderm Differentiation—SMAD4—breast cancer	0.000183	0.00327	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—PRL—breast cancer	0.000182	0.00326	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—NCOA1—breast cancer	0.000182	0.00326	CbGpPWpGaD
Desonide—Skin disorder—Goserelin—breast cancer	0.000182	0.00175	CcSEcCtD
Desonide—Hyperhidrosis—Goserelin—breast cancer	0.000181	0.00174	CcSEcCtD
Desonide—Rash—Anastrozole—breast cancer	0.00018	0.00174	CcSEcCtD
Desonide—Rash—Letrozole—breast cancer	0.00018	0.00174	CcSEcCtD
Desonide—Dermatitis—Letrozole—breast cancer	0.00018	0.00174	CcSEcCtD
Desonide—Dermatitis—Anastrozole—breast cancer	0.00018	0.00174	CcSEcCtD
Desonide—Irritability—Capecitabine—breast cancer	0.000179	0.00173	CcSEcCtD
Desonide—NR3C1—Adipogenesis—WNT1—breast cancer	0.000179	0.00321	CbGpPWpGaD
Desonide—Headache—Letrozole—breast cancer	0.000179	0.00173	CcSEcCtD
Desonide—Headache—Anastrozole—breast cancer	0.000179	0.00173	CcSEcCtD
Desonide—Cough—Vinorelbine—breast cancer	0.000179	0.00173	CcSEcCtD
Desonide—Hyperglycaemia—Paclitaxel—breast cancer	0.000179	0.00172	CcSEcCtD
Desonide—Dermatitis contact—Epirubicin—breast cancer	0.000178	0.00172	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—FOXM1—breast cancer	0.000177	0.00317	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—HIF1A—breast cancer	0.000177	0.00317	CbGpPWpGaD
Desonide—Infestation NOS—Paclitaxel—breast cancer	0.000177	0.0017	CcSEcCtD
Desonide—Infestation—Paclitaxel—breast cancer	0.000177	0.0017	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—breast cancer	0.000176	0.00316	CbGpPWpGaD
Desonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—breast cancer	0.000175	0.00314	CbGpPWpGaD
Desonide—Mediastinal disorder—Irinotecan—breast cancer	0.000175	0.00169	CcSEcCtD
Desonide—NR3C1—Adipogenesis—BMP4—breast cancer	0.000174	0.00312	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—breast cancer	0.000173	0.00167	CcSEcCtD
Desonide—Pain—Vinblastine—breast cancer	0.000172	0.00166	CcSEcCtD
Desonide—Skin exfoliation—Epirubicin—breast cancer	0.000172	0.00166	CcSEcCtD
Desonide—NR3C1—Generic Transcription Pathway—NR2F1—breast cancer	0.000172	0.00308	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—CSF2—breast cancer	0.000171	0.00307	CbGpPWpGaD
Desonide—Rash—Idarubicin—breast cancer	0.000171	0.00165	CcSEcCtD
Desonide—Rash—Raloxifene—breast cancer	0.000171	0.00165	CcSEcCtD
Desonide—Dermatitis—Raloxifene—breast cancer	0.000171	0.00165	CcSEcCtD
Desonide—Dermatitis—Idarubicin—breast cancer	0.000171	0.00165	CcSEcCtD
Desonide—Cough—Thiotepa—breast cancer	0.000171	0.00165	CcSEcCtD
Desonide—Mediastinal disorder—Gemcitabine—breast cancer	0.000171	0.00164	CcSEcCtD
Desonide—Headache—Raloxifene—breast cancer	0.00017	0.00164	CcSEcCtD
Desonide—Headache—Idarubicin—breast cancer	0.00017	0.00164	CcSEcCtD
Desonide—Erythema—Mitoxantrone—breast cancer	0.000169	0.00163	CcSEcCtD
Desonide—Pain—Tamoxifen—breast cancer	0.000167	0.00161	CcSEcCtD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—breast cancer	0.000166	0.00298	CbGpPWpGaD
Desonide—Infection—Vinorelbine—breast cancer	0.000166	0.0016	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—breast cancer	0.000166	0.0016	CcSEcCtD
Desonide—Dermatitis contact—Doxorubicin—breast cancer	0.000165	0.00159	CcSEcCtD
Desonide—Erythema—Gemcitabine—breast cancer	0.000165	0.00159	CcSEcCtD
Desonide—Nervous system disorder—Vinorelbine—breast cancer	0.000164	0.00158	CcSEcCtD
Desonide—Pain—Melphalan—breast cancer	0.000164	0.00158	CcSEcCtD
Desonide—Skin disorder—Vinorelbine—breast cancer	0.000163	0.00157	CcSEcCtD
Desonide—Asthma—Capecitabine—breast cancer	0.000162	0.00157	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—STAT5A—breast cancer	0.000162	0.00291	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—BMP2—breast cancer	0.000162	0.0029	CbGpPWpGaD
Desonide—Erythema—Fluorouracil—breast cancer	0.000162	0.00156	CcSEcCtD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—breast cancer	0.000162	0.0029	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—HNF4G—breast cancer	0.00016	0.00286	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—NR2F6—breast cancer	0.00016	0.00286	CbGpPWpGaD
Desonide—Pain—Goserelin—breast cancer	0.00016	0.00154	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—ALDOA—breast cancer	0.00016	0.00286	CbGpPWpGaD
Desonide—Skin exfoliation—Doxorubicin—breast cancer	0.000159	0.00154	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—breast cancer	0.000159	0.00284	CbGpPWpGaD
Desonide—Infection—Thiotepa—breast cancer	0.000159	0.00153	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—breast cancer	0.000159	0.00284	CbGpPWpGaD
Desonide—Pharyngitis—Paclitaxel—breast cancer	0.000157	0.00152	CcSEcCtD
Desonide—Nervous system disorder—Thiotepa—breast cancer	0.000157	0.00151	CcSEcCtD
Desonide—Oedema peripheral—Paclitaxel—breast cancer	0.000156	0.0015	CcSEcCtD
Desonide—Pruritus—Chlorambucil—breast cancer	0.000156	0.0015	CcSEcCtD
Desonide—Skin disorder—Thiotepa—breast cancer	0.000155	0.0015	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—breast cancer	0.000154	0.00276	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—GATA3—breast cancer	0.000152	0.00273	CbGpPWpGaD
Desonide—Upper respiratory tract infection—Capecitabine—breast cancer	0.000151	0.00146	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—CSF2—breast cancer	0.000151	0.0027	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CPT1A—breast cancer	0.000151	0.0027	CbGpPWpGaD
Desonide—Infestation—Docetaxel—breast cancer	0.00015	0.00144	CcSEcCtD
Desonide—Infestation NOS—Docetaxel—breast cancer	0.00015	0.00144	CcSEcCtD
Desonide—NR3C1—Adipogenesis—NCOA2—breast cancer	0.00015	0.00268	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—BAX—breast cancer	0.000149	0.00266	CbGpPWpGaD
Desonide—Cough—Mitoxantrone—breast cancer	0.000148	0.00142	CcSEcCtD
Desonide—Cough—Irinotecan—breast cancer	0.000148	0.00142	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—MMP1—breast cancer	0.000147	0.00264	CbGpPWpGaD
Desonide—Hyperglycaemia—Capecitabine—breast cancer	0.000147	0.00141	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—HIF1A—breast cancer	0.000146	0.00262	CbGpPWpGaD
Desonide—Infestation—Capecitabine—breast cancer	0.000145	0.0014	CcSEcCtD
Desonide—Infestation NOS—Capecitabine—breast cancer	0.000145	0.0014	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—PLAU—breast cancer	0.000145	0.00259	CbGpPWpGaD
Desonide—Cough—Gemcitabine—breast cancer	0.000144	0.00139	CcSEcCtD
Desonide—Betamethasone—PGR—breast cancer	0.000144	0.0431	CrCbGaD
Desonide—Pain—Vinorelbine—breast cancer	0.000143	0.00138	CcSEcCtD
Desonide—Mediastinal disorder—Paclitaxel—breast cancer	0.000143	0.00138	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	0.000139	0.00134	CcSEcCtD
Desonide—Mental disorder—Paclitaxel—breast cancer	0.000139	0.00134	CcSEcCtD
Desonide—Pruritus—Tamoxifen—breast cancer	0.000138	0.00133	CcSEcCtD
Desonide—Erythema—Paclitaxel—breast cancer	0.000138	0.00133	CcSEcCtD
Desonide—Infection—Mitoxantrone—breast cancer	0.000137	0.00132	CcSEcCtD
Desonide—Infection—Irinotecan—breast cancer	0.000137	0.00132	CcSEcCtD
Desonide—Pain—Thiotepa—breast cancer	0.000137	0.00132	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—ESR1—breast cancer	0.000136	0.00244	CbGpPWpGaD
Desonide—NR3C1—Circadian Clock—SERPINE1—breast cancer	0.000136	0.00243	CbGpPWpGaD
Desonide—Pruritus—Melphalan—breast cancer	0.000136	0.00131	CcSEcCtD
Desonide—Nervous system disorder—Irinotecan—breast cancer	0.000135	0.00131	CcSEcCtD
Desonide—NR3C1—Endoderm Differentiation—NOTCH1—breast cancer	0.000135	0.00241	CbGpPWpGaD
Desonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—breast cancer	0.000134	0.00241	CbGpPWpGaD
Desonide—Skin disorder—Mitoxantrone—breast cancer	0.000134	0.00129	CcSEcCtD
Desonide—Infection—Gemcitabine—breast cancer	0.000134	0.00129	CcSEcCtD
Desonide—Irritability—Methotrexate—breast cancer	0.000134	0.00129	CcSEcCtD
Desonide—Hyperhidrosis—Mitoxantrone—breast cancer	0.000133	0.00129	CcSEcCtD
Desonide—Hyperhidrosis—Irinotecan—breast cancer	0.000133	0.00129	CcSEcCtD
Desonide—Pharyngitis—Docetaxel—breast cancer	0.000133	0.00129	CcSEcCtD
Desonide—Oedema peripheral—Docetaxel—breast cancer	0.000132	0.00128	CcSEcCtD
Desonide—Pruritus—Goserelin—breast cancer	0.000132	0.00127	CcSEcCtD
Desonide—Nervous system disorder—Gemcitabine—breast cancer	0.000132	0.00127	CcSEcCtD
Desonide—NR3C1—Endoderm Differentiation—APC—breast cancer	0.000132	0.00236	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—GATA3—breast cancer	0.000132	0.00236	CbGpPWpGaD
Desonide—Infection—Fluorouracil—breast cancer	0.000131	0.00127	CcSEcCtD
Desonide—Skin disorder—Gemcitabine—breast cancer	0.000131	0.00126	CcSEcCtD
Desonide—Hyperhidrosis—Gemcitabine—breast cancer	0.00013	0.00125	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—breast cancer	0.00013	0.00232	CbGpPWpGaD
Desonide—Nervous system disorder—Fluorouracil—breast cancer	0.00013	0.00125	CcSEcCtD
Desonide—Pharyngitis—Capecitabine—breast cancer	0.000129	0.00124	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—breast cancer	0.000129	0.0023	CbGpPWpGaD
Desonide—Oedema peripheral—Capecitabine—breast cancer	0.000128	0.00123	CcSEcCtD
Desonide—NR3C1—Regulation of Androgen receptor activity—MDM2—breast cancer	0.000127	0.00227	CbGpPWpGaD
Desonide—Headache—Vinblastine—breast cancer	0.000126	0.00122	CcSEcCtD
Desonide—NR3C1—Adipogenesis—NCOA1—breast cancer	0.000126	0.00226	CbGpPWpGaD
Desonide—Rash—Tamoxifen—breast cancer	0.000123	0.00119	CcSEcCtD
Desonide—Dermatitis—Tamoxifen—breast cancer	0.000123	0.00119	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—FOS—breast cancer	0.000123	0.0022	CbGpPWpGaD
Desonide—Headache—Tamoxifen—breast cancer	0.000123	0.00118	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—breast cancer	0.000122	0.00218	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—breast cancer	0.000121	0.00217	CbGpPWpGaD
Desonide—Mediastinal disorder—Docetaxel—breast cancer	0.000121	0.00117	CcSEcCtD
Desonide—Asthma—Methotrexate—breast cancer	0.000121	0.00117	CcSEcCtD
Desonide—Rash—Melphalan—breast cancer	0.000121	0.00116	CcSEcCtD
Desonide—Dermatitis—Melphalan—breast cancer	0.000121	0.00116	CcSEcCtD
Desonide—Cough—Paclitaxel—breast cancer	0.00012	0.00116	CcSEcCtD
Desonide—Triamcinolone—BCHE—breast cancer	0.00012	0.036	CrCbGaD
Desonide—NR3C1—Gene Expression—ZNF432—breast cancer	0.000119	0.00214	CbGpPWpGaD
Desonide—Pruritus—Vinorelbine—breast cancer	0.000118	0.00114	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—ESR2—breast cancer	0.000118	0.00212	CbGpPWpGaD
Desonide—Pain—Mitoxantrone—breast cancer	0.000118	0.00114	CcSEcCtD
Desonide—Pain—Irinotecan—breast cancer	0.000118	0.00114	CcSEcCtD
Desonide—Rash—Goserelin—breast cancer	0.000118	0.00114	CcSEcCtD
Desonide—Dermatitis—Goserelin—breast cancer	0.000118	0.00113	CcSEcCtD
Desonide—Mental disorder—Docetaxel—breast cancer	0.000118	0.00113	CcSEcCtD
Desonide—Mediastinal disorder—Capecitabine—breast cancer	0.000117	0.00113	CcSEcCtD
Desonide—Headache—Goserelin—breast cancer	0.000117	0.00113	CcSEcCtD
Desonide—Erythema—Docetaxel—breast cancer	0.000117	0.00113	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000117	0.00112	CcSEcCtD
Desonide—Pain—Gemcitabine—breast cancer	0.000115	0.00111	CcSEcCtD
Desonide—Mental disorder—Capecitabine—breast cancer	0.000114	0.0011	CcSEcCtD
Desonide—NR3C1—Generic Transcription Pathway—ESRRA—breast cancer	0.000114	0.00204	CbGpPWpGaD
Desonide—Erythema—Capecitabine—breast cancer	0.000113	0.00109	CcSEcCtD
Desonide—Asthma—Epirubicin—breast cancer	0.000113	0.00109	CcSEcCtD
Desonide—Pruritus—Thiotepa—breast cancer	0.000113	0.00109	CcSEcCtD
Desonide—Pain—Fluorouracil—breast cancer	0.000113	0.00109	CcSEcCtD
Desonide—Clobetasol propionate—CYP1A1—breast cancer	0.000113	0.0338	CrCbGaD
Desonide—Dexamethasone—CYP17A1—breast cancer	0.000113	0.0338	CrCbGaD
Desonide—Upper respiratory tract infection—Methotrexate—breast cancer	0.000112	0.00108	CcSEcCtD
Desonide—NR3C1—Adipogenesis—STAT5A—breast cancer	0.000112	0.00201	CbGpPWpGaD
Desonide—Infection—Paclitaxel—breast cancer	0.000112	0.00108	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—EGR1—breast cancer	0.000111	0.00198	CbGpPWpGaD
Desonide—Nervous system disorder—Paclitaxel—breast cancer	0.00011	0.00106	CcSEcCtD
Desonide—NR3C1—Regulation of Androgen receptor activity—JUN—breast cancer	0.00011	0.00197	CbGpPWpGaD
Desonide—Skin disorder—Paclitaxel—breast cancer	0.000109	0.00105	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—breast cancer	0.000109	0.00195	CbGpPWpGaD
Desonide—Hyperhidrosis—Paclitaxel—breast cancer	0.000109	0.00105	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—FOS—breast cancer	0.000108	0.00194	CbGpPWpGaD
Desonide—Infestation NOS—Methotrexate—breast cancer	0.000108	0.00104	CcSEcCtD
Desonide—Infestation—Methotrexate—breast cancer	0.000108	0.00104	CcSEcCtD
Desonide—NR3C1—Adipogenesis—NCOR1—breast cancer	0.000106	0.00189	CbGpPWpGaD
Desonide—Rash—Vinorelbine—breast cancer	0.000106	0.00102	CcSEcCtD
Desonide—Dermatitis—Vinorelbine—breast cancer	0.000105	0.00102	CcSEcCtD
Desonide—Upper respiratory tract infection—Epirubicin—breast cancer	0.000105	0.00101	CcSEcCtD
Desonide—Headache—Vinorelbine—breast cancer	0.000105	0.00101	CcSEcCtD
Desonide—Hydrocortisone—SHBG—breast cancer	0.000105	0.0315	CrCbGaD
Desonide—Asthma—Doxorubicin—breast cancer	0.000105	0.00101	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—AR—breast cancer	0.000104	0.00187	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—breast cancer	0.000104	0.00186	CbGpPWpGaD
Desonide—Sweating—Methotrexate—breast cancer	0.000103	0.000997	CcSEcCtD
Desonide—NR3C1—Generic Transcription Pathway—THRB—breast cancer	0.000103	0.00184	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—E2F1—breast cancer	0.000102	0.00183	CbGpPWpGaD
Desonide—Hyperglycaemia—Epirubicin—breast cancer	0.000102	0.000984	CcSEcCtD
Desonide—Cough—Docetaxel—breast cancer	0.000102	0.000984	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—IFNG—breast cancer	0.000102	0.00182	CbGpPWpGaD
Desonide—Infestation NOS—Epirubicin—breast cancer	0.000101	0.000973	CcSEcCtD
Desonide—Infestation—Epirubicin—breast cancer	0.000101	0.000973	CcSEcCtD
Desonide—Rash—Thiotepa—breast cancer	0.000101	0.000972	CcSEcCtD
Desonide—Dermatitis—Thiotepa—breast cancer	0.000101	0.000971	CcSEcCtD
Desonide—Headache—Thiotepa—breast cancer	0.0001	0.000965	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—breast cancer	9.96e-05	0.00178	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	9.89e-05	0.000953	CcSEcCtD
Desonide—Cough—Capecitabine—breast cancer	9.88e-05	0.000952	CcSEcCtD
Desonide—NR3C1—Generic Transcription Pathway—RXRB—breast cancer	9.88e-05	0.00177	CbGpPWpGaD
Desonide—NR3C1—Regulation of Androgen receptor activity—SRC—breast cancer	9.87e-05	0.00177	CbGpPWpGaD
Desonide—Betamethasone—CYP19A1—breast cancer	9.86e-05	0.0296	CrCbGaD
Desonide—Upper respiratory tract infection—Doxorubicin—breast cancer	9.74e-05	0.000938	CcSEcCtD
Desonide—Sweating—Epirubicin—breast cancer	9.68e-05	0.000933	CcSEcCtD
Desonide—Pain—Paclitaxel—breast cancer	9.63e-05	0.000928	CcSEcCtD
Desonide—Pharyngitis—Methotrexate—breast cancer	9.61e-05	0.000926	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	9.57e-05	0.000923	CcSEcCtD
Desonide—Pruritus—Gemcitabine—breast cancer	9.52e-05	0.000917	CcSEcCtD
Desonide—Infection—Docetaxel—breast cancer	9.48e-05	0.000914	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—CXCL8—breast cancer	9.48e-05	0.0017	CbGpPWpGaD
Desonide—Hyperglycaemia—Doxorubicin—breast cancer	9.45e-05	0.000911	CcSEcCtD
Desonide—Nervous system disorder—Docetaxel—breast cancer	9.36e-05	0.000902	CcSEcCtD
Desonide—Pruritus—Fluorouracil—breast cancer	9.36e-05	0.000902	CcSEcCtD
Desonide—Infestation NOS—Doxorubicin—breast cancer	9.34e-05	0.0009	CcSEcCtD
Desonide—Infestation—Doxorubicin—breast cancer	9.34e-05	0.0009	CcSEcCtD
Desonide—Skin disorder—Docetaxel—breast cancer	9.27e-05	0.000894	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—CDKN1B—breast cancer	9.25e-05	0.00166	CbGpPWpGaD
Desonide—Hydrocortamate—CYP3A4—breast cancer	9.22e-05	0.0277	CrCbGaD
Desonide—Dexamethasone—NOS2—breast cancer	9.19e-05	0.0276	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—HES1—breast cancer	9.18e-05	0.00164	CbGpPWpGaD
Desonide—Infection—Capecitabine—breast cancer	9.18e-05	0.000885	CcSEcCtD
Desonide—Nervous system disorder—Capecitabine—breast cancer	9.06e-05	0.000873	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—IL2—breast cancer	9.06e-05	0.00162	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—HNRNPR—breast cancer	9.05e-05	0.00162	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—HNRNPK—breast cancer	9.05e-05	0.00162	CbGpPWpGaD
Desonide—Pharyngitis—Epirubicin—breast cancer	8.99e-05	0.000867	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—breast cancer	8.98e-05	0.00161	CbGpPWpGaD
Desonide—Skin disorder—Capecitabine—breast cancer	8.98e-05	0.000865	CcSEcCtD
Desonide—Sweating—Doxorubicin—breast cancer	8.95e-05	0.000863	CcSEcCtD
Desonide—NR3C1—Endoderm Differentiation—CTNNB1—breast cancer	8.95e-05	0.0016	CbGpPWpGaD
Desonide—Hyperhidrosis—Capecitabine—breast cancer	8.93e-05	0.000861	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—breast cancer	8.93e-05	0.0016	CbGpPWpGaD
Desonide—Oedema peripheral—Epirubicin—breast cancer	8.93e-05	0.00086	CcSEcCtD
Desonide—NR3C1—Adipogenesis—HIF1A—breast cancer	8.9e-05	0.00159	CbGpPWpGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—breast cancer	8.86e-05	0.00159	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—CCND1—breast cancer	8.83e-05	0.00158	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—JUN—breast cancer	8.81e-05	0.00158	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—CTNNB1—breast cancer	8.74e-05	0.00157	CbGpPWpGaD
Desonide—Mediastinal disorder—Methotrexate—breast cancer	8.73e-05	0.000841	CcSEcCtD
Desonide—Rash—Irinotecan—breast cancer	8.71e-05	0.000839	CcSEcCtD
Desonide—Rash—Mitoxantrone—breast cancer	8.71e-05	0.000839	CcSEcCtD
Desonide—Dermatitis—Mitoxantrone—breast cancer	8.7e-05	0.000838	CcSEcCtD
Desonide—Dermatitis—Irinotecan—breast cancer	8.7e-05	0.000838	CcSEcCtD
Desonide—NR3C1—Adipogenesis—LEP—breast cancer	8.69e-05	0.00156	CbGpPWpGaD
Desonide—Headache—Mitoxantrone—breast cancer	8.65e-05	0.000834	CcSEcCtD
Desonide—Headache—Irinotecan—breast cancer	8.65e-05	0.000834	CcSEcCtD
Desonide—Budesonide—CYP3A4—breast cancer	8.57e-05	0.0257	CrCbGaD
Desonide—NR3C1—AP-1 transcription factor network—MMP9—breast cancer	8.57e-05	0.00153	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—PTEN—breast cancer	8.52e-05	0.00153	CbGpPWpGaD
Desonide—Mental disorder—Methotrexate—breast cancer	8.48e-05	0.000818	CcSEcCtD
Desonide—Rash—Gemcitabine—breast cancer	8.48e-05	0.000817	CcSEcCtD
Desonide—Dermatitis—Gemcitabine—breast cancer	8.47e-05	0.000817	CcSEcCtD
Desonide—Erythema—Methotrexate—breast cancer	8.43e-05	0.000812	CcSEcCtD
Desonide—Headache—Gemcitabine—breast cancer	8.43e-05	0.000812	CcSEcCtD
Desonide—Dexamethasone—PGR—breast cancer	8.36e-05	0.0251	CrCbGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—breast cancer	8.35e-05	0.0015	CbGpPWpGaD
Desonide—Rash—Fluorouracil—breast cancer	8.34e-05	0.000804	CcSEcCtD
Desonide—Dermatitis—Fluorouracil—breast cancer	8.33e-05	0.000803	CcSEcCtD
Desonide—Pharyngitis—Doxorubicin—breast cancer	8.32e-05	0.000802	CcSEcCtD
Desonide—Headache—Fluorouracil—breast cancer	8.28e-05	0.000798	CcSEcCtD
Desonide—NR3C1—Gene Expression—NR2F1—breast cancer	8.28e-05	0.00148	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—EEF1B2—breast cancer	8.28e-05	0.00148	CbGpPWpGaD
Desonide—Oedema peripheral—Doxorubicin—breast cancer	8.26e-05	0.000796	CcSEcCtD
Desonide—Mediastinal disorder—Epirubicin—breast cancer	8.17e-05	0.000787	CcSEcCtD
Desonide—Pain—Docetaxel—breast cancer	8.16e-05	0.000787	CcSEcCtD
Desonide—Ciclesonide—CYP2D6—breast cancer	8.15e-05	0.0245	CrCbGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—breast cancer	7.98e-05	0.00143	CbGpPWpGaD
Desonide—Pruritus—Paclitaxel—breast cancer	7.97e-05	0.000768	CcSEcCtD
Desonide—Mental disorder—Epirubicin—breast cancer	7.94e-05	0.000765	CcSEcCtD
Desonide—Pain—Capecitabine—breast cancer	7.9e-05	0.000762	CcSEcCtD
Desonide—Erythema—Epirubicin—breast cancer	7.89e-05	0.00076	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—breast cancer	7.84e-05	0.0014	CbGpPWpGaD
Desonide—Dexamethasone—CYP1B1—breast cancer	7.81e-05	0.0234	CrCbGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—breast cancer	7.76e-05	0.00139	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—NR2F6—breast cancer	7.7e-05	0.00138	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—HNF4G—breast cancer	7.7e-05	0.00138	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—breast cancer	7.69e-05	0.00138	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—breast cancer	7.6e-05	0.00136	CbGpPWpGaD
Desonide—Mediastinal disorder—Doxorubicin—breast cancer	7.56e-05	0.000728	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—breast cancer	7.52e-05	0.00135	CbGpPWpGaD
Desonide—Alclometasone—CYP3A4—breast cancer	7.39e-05	0.0222	CrCbGaD
Desonide—Cough—Methotrexate—breast cancer	7.36e-05	0.000709	CcSEcCtD
Desonide—Mental disorder—Doxorubicin—breast cancer	7.35e-05	0.000708	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—breast cancer	7.34e-05	0.00132	CbGpPWpGaD
Desonide—Erythema—Doxorubicin—breast cancer	7.3e-05	0.000703	CcSEcCtD
Desonide—NR3C1—Adipogenesis—RB1—breast cancer	7.24e-05	0.0013	CbGpPWpGaD
Desonide—NR3C1—Endoderm Differentiation—TGFB1—breast cancer	7.23e-05	0.00129	CbGpPWpGaD
Desonide—Hydrocortisone—ABCG2—breast cancer	7.23e-05	0.0217	CrCbGaD
Desonide—Flunisolide—CYP3A4—breast cancer	7.19e-05	0.0216	CrCbGaD
Desonide—NR3C1—Adipogenesis—IGF1—breast cancer	7.18e-05	0.00129	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—RARB—breast cancer	7.14e-05	0.00128	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	7.13e-05	0.000687	CcSEcCtD
Desonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—breast cancer	7.12e-05	0.00127	CbGpPWpGaD
Desonide—Paramethasone—CYP3A4—breast cancer	7.1e-05	0.0213	CrCbGaD
Desonide—Rash—Paclitaxel—breast cancer	7.1e-05	0.000684	CcSEcCtD
Desonide—Dermatitis—Paclitaxel—breast cancer	7.09e-05	0.000684	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—MYC—breast cancer	7.08e-05	0.00127	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—TGFB1—breast cancer	7.06e-05	0.00126	CbGpPWpGaD
Desonide—Headache—Paclitaxel—breast cancer	7.05e-05	0.00068	CcSEcCtD
Desonide—Ciclesonide—CYP3A4—breast cancer	6.99e-05	0.021	CrCbGaD
Desonide—Fluorometholone—CYP3A4—breast cancer	6.93e-05	0.0208	CrCbGaD
Desonide—Cough—Epirubicin—breast cancer	6.88e-05	0.000663	CcSEcCtD
Desonide—NR3C1—Gene Expression—HNRNPL—breast cancer	6.86e-05	0.00123	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—MED12—breast cancer	6.85e-05	0.00123	CbGpPWpGaD
Desonide—Infection—Methotrexate—breast cancer	6.83e-05	0.000659	CcSEcCtD
Desonide—NR3C1—Adipogenesis—SERPINE1—breast cancer	6.82e-05	0.00122	CbGpPWpGaD
Desonide—Pruritus—Docetaxel—breast cancer	6.75e-05	0.000651	CcSEcCtD
Desonide—Nervous system disorder—Methotrexate—breast cancer	6.75e-05	0.00065	CcSEcCtD
Desonide—Methylprednisolone—CYP3A4—breast cancer	6.7e-05	0.0201	CrCbGaD
Desonide—Skin disorder—Methotrexate—breast cancer	6.68e-05	0.000644	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	6.67e-05	0.000643	CcSEcCtD
Desonide—Hyperhidrosis—Methotrexate—breast cancer	6.65e-05	0.000641	CcSEcCtD
Desonide—Pruritus—Capecitabine—breast cancer	6.54e-05	0.00063	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—breast cancer	6.41e-05	0.00115	CbGpPWpGaD
Desonide—Infection—Epirubicin—breast cancer	6.4e-05	0.000616	CcSEcCtD
Desonide—Cough—Doxorubicin—breast cancer	6.37e-05	0.000614	CcSEcCtD
Desonide—Nervous system disorder—Epirubicin—breast cancer	6.31e-05	0.000609	CcSEcCtD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—breast cancer	6.3e-05	0.00113	CbGpPWpGaD
Desonide—Skin disorder—Epirubicin—breast cancer	6.25e-05	0.000603	CcSEcCtD
Desonide—Hyperhidrosis—Epirubicin—breast cancer	6.22e-05	0.0006	CcSEcCtD
Desonide—NR3C1—Generic Transcription Pathway—NOTCH4—breast cancer	6.2e-05	0.00111	CbGpPWpGaD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	6.17e-05	0.000595	CcSEcCtD
Desonide—Rash—Docetaxel—breast cancer	6.02e-05	0.00058	CcSEcCtD
Desonide—Dermatitis—Docetaxel—breast cancer	6.01e-05	0.00058	CcSEcCtD
Desonide—Headache—Docetaxel—breast cancer	5.98e-05	0.000576	CcSEcCtD
Desonide—Infection—Doxorubicin—breast cancer	5.92e-05	0.00057	CcSEcCtD
Desonide—Pain—Methotrexate—breast cancer	5.88e-05	0.000567	CcSEcCtD
Desonide—Nervous system disorder—Doxorubicin—breast cancer	5.84e-05	0.000563	CcSEcCtD
Desonide—Rash—Capecitabine—breast cancer	5.83e-05	0.000562	CcSEcCtD
Desonide—Dermatitis—Capecitabine—breast cancer	5.82e-05	0.000561	CcSEcCtD
Desonide—NR3C1—AP-1 transcription factor network—TP53—breast cancer	5.81e-05	0.00104	CbGpPWpGaD
Desonide—Headache—Capecitabine—breast cancer	5.79e-05	0.000558	CcSEcCtD
Desonide—Skin disorder—Doxorubicin—breast cancer	5.79e-05	0.000558	CcSEcCtD
Desonide—Hyperhidrosis—Doxorubicin—breast cancer	5.76e-05	0.000555	CcSEcCtD
Desonide—Dexamethasone—CYP19A1—breast cancer	5.73e-05	0.0172	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—PGR—breast cancer	5.67e-05	0.00102	CbGpPWpGaD
Desonide—Triamcinolone—CYP3A4—breast cancer	5.65e-05	0.017	CrCbGaD
Desonide—NR3C1—Gene Expression—EIF2S2—breast cancer	5.65e-05	0.00101	CbGpPWpGaD
Desonide—Methylprednisolone—ABCB1—breast cancer	5.58e-05	0.0167	CrCbGaD
Desonide—Triamcinolone—PTGS2—breast cancer	5.53e-05	0.0166	CrCbGaD
Desonide—Pain—Epirubicin—breast cancer	5.51e-05	0.000531	CcSEcCtD
Desonide—NR3C1—Gene Expression—ESRRA—breast cancer	5.49e-05	0.000982	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—NCOA2—breast cancer	5.46e-05	0.000978	CbGpPWpGaD
Desonide—Dexamethasone—ABCG2—breast cancer	5.39e-05	0.0162	CrCbGaD
Desonide—NR3C1—Adipogenesis—CTNNB1—breast cancer	5.33e-05	0.000954	CbGpPWpGaD
Desonide—NR3C1—AP-1 transcription factor network—IL6—breast cancer	5.32e-05	0.000953	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—NOTCH3—breast cancer	5.27e-05	0.000944	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—PARP1—breast cancer	5.27e-05	0.000944	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—CDKN1A—breast cancer	5.2e-05	0.000932	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—YBX1—breast cancer	5.2e-05	0.000931	CbGpPWpGaD
Desonide—Prednisone—CYP3A4—breast cancer	5.13e-05	0.0154	CrCbGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—breast cancer	5.12e-05	0.000917	CbGpPWpGaD
Desonide—Pain—Doxorubicin—breast cancer	5.09e-05	0.000491	CcSEcCtD
Desonide—NR3C1—Generic Transcription Pathway—ESR2—breast cancer	4.99e-05	0.000894	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—breast cancer	4.99e-05	0.000894	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—EEF2—breast cancer	4.96e-05	0.000888	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—THRB—breast cancer	4.96e-05	0.000888	CbGpPWpGaD
Desonide—Pruritus—Methotrexate—breast cancer	4.87e-05	0.000469	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL1B—breast cancer	4.79e-05	0.000857	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CASP3—breast cancer	4.78e-05	0.000855	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—TET2—breast cancer	4.76e-05	0.000852	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—RXRB—breast cancer	4.76e-05	0.000852	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—NOTCH2—breast cancer	4.73e-05	0.000847	CbGpPWpGaD
Desonide—Prednisolone—CYP3A4—breast cancer	4.73e-05	0.0142	CrCbGaD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—breast cancer	4.69e-05	0.00084	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—RPL31—breast cancer	4.66e-05	0.000835	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—STAT3—breast cancer	4.64e-05	0.000832	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—JUN—breast cancer	4.64e-05	0.000831	CbGpPWpGaD
Desonide—Betamethasone—CYP3A4—breast cancer	4.63e-05	0.0139	CrCbGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—breast cancer	4.6e-05	0.000825	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—NCOA1—breast cancer	4.6e-05	0.000824	CbGpPWpGaD
Desonide—Pruritus—Epirubicin—breast cancer	4.55e-05	0.000439	CcSEcCtD
Desonide—Betamethasone—PTGS2—breast cancer	4.53e-05	0.0136	CrCbGaD
Desonide—Prednisone—ALB—breast cancer	4.47e-05	0.0134	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—AR—breast cancer	4.41e-05	0.00079	CbGpPWpGaD
Desonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—breast cancer	4.37e-05	0.000782	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—RPS4X—breast cancer	4.35e-05	0.000779	CbGpPWpGaD
Desonide—Rash—Methotrexate—breast cancer	4.34e-05	0.000418	CcSEcCtD
Desonide—Dermatitis—Methotrexate—breast cancer	4.33e-05	0.000418	CcSEcCtD
Desonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—breast cancer	4.33e-05	0.000775	CbGpPWpGaD
Desonide—Headache—Methotrexate—breast cancer	4.31e-05	0.000415	CcSEcCtD
Desonide—NR3C1—Adipogenesis—TGFB1—breast cancer	4.3e-05	0.000771	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—EIF3A—breast cancer	4.28e-05	0.000767	CbGpPWpGaD
Desonide—Prednisone—ABCB1—breast cancer	4.27e-05	0.0128	CrCbGaD
Desonide—Dexamethasone—CYP1A1—breast cancer	4.22e-05	0.0127	CrCbGaD
Desonide—NR3C1—Gene Expression—DNMT3A—breast cancer	4.22e-05	0.000755	CbGpPWpGaD
Desonide—Pruritus—Doxorubicin—breast cancer	4.21e-05	0.000406	CcSEcCtD
Desonide—NR3C1—Gene Expression—ELL—breast cancer	4.16e-05	0.000744	CbGpPWpGaD
Desonide—Rash—Epirubicin—breast cancer	4.06e-05	0.000391	CcSEcCtD
Desonide—Dermatitis—Epirubicin—breast cancer	4.06e-05	0.000391	CcSEcCtD
Desonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—breast cancer	4.05e-05	0.000726	CbGpPWpGaD
Desonide—Headache—Epirubicin—breast cancer	4.03e-05	0.000389	CcSEcCtD
Desonide—NR3C1—Adipogenesis—TNF—breast cancer	4.02e-05	0.00072	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—SMAD4—breast cancer	3.97e-05	0.000711	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—VDR—breast cancer	3.96e-05	0.00071	CbGpPWpGaD
Desonide—Prednisolone—ABCB1—breast cancer	3.93e-05	0.0118	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—NCOR1—breast cancer	3.86e-05	0.000691	CbGpPWpGaD
Desonide—Betamethasone—ABCB1—breast cancer	3.85e-05	0.0116	CrCbGaD
Desonide—NR3C1—Gene Expression—PABPC1—breast cancer	3.85e-05	0.000689	CbGpPWpGaD
Desonide—Rash—Doxorubicin—breast cancer	3.76e-05	0.000362	CcSEcCtD
Desonide—Dermatitis—Doxorubicin—breast cancer	3.75e-05	0.000362	CcSEcCtD
Desonide—Headache—Doxorubicin—breast cancer	3.73e-05	0.00036	CcSEcCtD
Desonide—Hydrocortisone—CYP3A4—breast cancer	3.61e-05	0.0108	CrCbGaD
Desonide—NR3C1—Gene Expression—DNMT3B—breast cancer	3.6e-05	0.000645	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—RPL23A—breast cancer	3.53e-05	0.000633	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—TNF—breast cancer	3.47e-05	0.000622	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—HIST1H2BK—breast cancer	3.47e-05	0.000621	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—HIST1H2BC—breast cancer	3.47e-05	0.000621	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—RARB—breast cancer	3.44e-05	0.000616	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—MED12—breast cancer	3.3e-05	0.00059	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—RPS8—breast cancer	3.3e-05	0.00059	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—RPS7—breast cancer	3.3e-05	0.00059	CbGpPWpGaD
Desonide—NR3C1—Adipogenesis—IL6—breast cancer	3.24e-05	0.000581	CbGpPWpGaD
Desonide—Dexamethasone—CYP2D6—breast cancer	3.14e-05	0.00942	CrCbGaD
Desonide—NR3C1—Generic Transcription Pathway—ESR1—breast cancer	3.03e-05	0.000542	CbGpPWpGaD
Desonide—Hydrocortisone—ABCB1—breast cancer	3.01e-05	0.00903	CrCbGaD
Desonide—NR3C1—Gene Expression—NOTCH4—breast cancer	2.99e-05	0.000535	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—NOTCH1—breast cancer	2.93e-05	0.000524	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—HSPA1B—breast cancer	2.85e-05	0.00051	CbGpPWpGaD
Desonide—NR3C1—SIDS Susceptibility Pathways—IL6—breast cancer	2.8e-05	0.000502	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—PGR—breast cancer	2.73e-05	0.000489	CbGpPWpGaD
Desonide—Dexamethasone—CYP3A4—breast cancer	2.69e-05	0.00808	CrCbGaD
Desonide—NR3C1—Gene Expression—DNMT1—breast cancer	2.68e-05	0.00048	CbGpPWpGaD
Desonide—Dexamethasone—PTGS2—breast cancer	2.64e-05	0.00791	CrCbGaD
Desonide—NR3C1—Gene Expression—NCOA2—breast cancer	2.63e-05	0.000471	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—EZH2—breast cancer	2.59e-05	0.000465	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—NOTCH3—breast cancer	2.54e-05	0.000455	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—PARP1—breast cancer	2.54e-05	0.000455	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—SERPINE1—breast cancer	2.49e-05	0.000446	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—RPS6—breast cancer	2.48e-05	0.000444	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—ESR2—breast cancer	2.4e-05	0.000431	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—NOTCH2—breast cancer	2.28e-05	0.000408	CbGpPWpGaD
Desonide—Dexamethasone—ABCB1—breast cancer	2.24e-05	0.00673	CrCbGaD
Desonide—NR3C1—Gene Expression—NCOA1—breast cancer	2.22e-05	0.000397	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—AR—breast cancer	2.12e-05	0.00038	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—SIRT1—breast cancer	1.94e-05	0.000347	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—SMAD4—breast cancer	1.91e-05	0.000342	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—VDR—breast cancer	1.91e-05	0.000342	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—NCOR1—breast cancer	1.86e-05	0.000332	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—H2AFX—breast cancer	1.81e-05	0.000324	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—ERCC2—breast cancer	1.75e-05	0.000313	CbGpPWpGaD
Desonide—NR3C1—Generic Transcription Pathway—MYC—breast cancer	1.58e-05	0.000282	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—ESR1—breast cancer	1.46e-05	0.000261	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—NOTCH1—breast cancer	1.41e-05	0.000252	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—SERPINE1—breast cancer	1.2e-05	0.000215	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—MAPK3—breast cancer	7.8e-06	0.00014	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—MYC—breast cancer	7.59e-06	0.000136	CbGpPWpGaD
Desonide—NR3C1—Gene Expression—AKT1—breast cancer	5.26e-06	9.42e-05	CbGpPWpGaD
